checkAd
    Startseite > Aktien > Femasys > Nachrichten
    Femasys Aktie
    1,2800
     
    USD
    +1,59 %
    +0,0200 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,2600
     
    USD
    900 STK
    Geldkurs 21.05.24
    1,2800
     
    USD
    1.100 STK
    Briefkurs 21.05.24
    ISIN: US31447E1055 · WKN: A3CYX9 · SYM: FEMY · USA

    Neueste Nachrichten

    Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
    17.05.24 · globenewswire · Femasys
    Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
    16.05.24 · globenewswire · Femasys
    Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
    09.05.24 · globenewswire · Femasys
    Femasys Expands Commercial Management Team with Addition of Experienced New Hires
    07.05.24 · globenewswire · Femasys
    Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
    18.04.24 · globenewswire · Femasys
    Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
    28.03.24 · globenewswire · Femasys
    Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
    21.03.24 · globenewswire · Femasys
    Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed for the Treatment of Infertility
    20.03.24 · globenewswire · Femasys
    Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
    13.03.24 · globenewswire · Femasys
    Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
    06.03.24 · globenewswire · Femasys
    Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
    28.02.24 · globenewswire · Femasys
    Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
    06.02.24 · globenewswire · Femasys